Ledger.Open graph →
SEC Form D · filed April 15, 2022

Eumentis Therapeutics, Inc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEWTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Andrew Pearlman · Newton, MADirectorMaryann Bryla · Newton, MADirectorRandall Marshall · Newton, MAExecMark Tepper · Newton, MAExec · DirectorJames Larrick · Newton, MADirectorThomas Roeder · Nantucket, MADirectorAdrian Bot · San Diego, CAExecMichael Baran · San Diego, CADirectorMats N. Eklund · St Helier, Y9DirectorCarsten D. Koppen · St Helier, Y9Exec · DirectorAmar Kapur · Newton, MADirectorSteve B. Kim · San Mateo, CADirectorS. C. Honig · San Mateo, CAExec · DirectorRobby Peters · San Mateo, CADirectorAndrew E. Braithwaite · Salt Lake City, UTExecSophia Dilbert · Grand Cayman, Cayman IslandsDirectorAmar Kapur · Newton, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗